Article info
PDFInnovations
Dexamethasone intravitreal implant as adjunct therapy for patients with wet age-related macular degeneration with incomplete response to ranibizumab
- Correspondence to Dr Michael Brent, Department of Ophthalmology, Toronto Western Hospital, UHN, 6E-423 399 Bathurst Street, Toronto, Ontario, Canada M5T2S8; mh.brent{at}utoronto.ca
Citation
Dexamethasone intravitreal implant as adjunct therapy for patients with wet age-related macular degeneration with incomplete response to ranibizumab
Publication history
- Received June 15, 2014
- Revised October 14, 2014
- Accepted November 10, 2014
- First published November 25, 2014.
Online issue publication
May 25, 2016
Article Versions
- Previous version (25 May 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions